Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1969 Apr 26;2(5651):209–212. doi: 10.1136/bmj.2.5651.209

Some principles in the chemotherapy of bacterial infections. II.

J Crofton
PMCID: PMC1983080  PMID: 5780427

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. S. Facteurs de transfert et résistance aux antibiotiques chez les entérobactéries. Ann Inst Pasteur (Paris) 1967 May;112(5):547–563. [PubMed] [Google Scholar]
  2. Bach J. A., Buono N., Chisholm D., Price K. E., Pursiano T. A., Gourevitch A. In vitro and in vivo synergism of mixtures of penicillins. Antimicrob Agents Chemother (Bethesda) 1966;6:328–336. [PubMed] [Google Scholar]
  3. CLAYSON C. Sir Robert Philip and the conquest of tuberculosis. Br Med J. 1957 Dec 28;2(5060):1503–1508. doi: 10.1136/bmj.2.5060.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carter W., McCarty K. S. Molecular mechanisms of antibiotic action. Ann Intern Med. 1966 May;64(5):1087–1113. doi: 10.7326/0003-4819-64-5-1087. [DOI] [PubMed] [Google Scholar]
  5. DAVIES J., GILBERT W., GORINI L. STREPTOMYCIN, SUPPRESSION, AND THE CODE. Proc Natl Acad Sci U S A. 1964 May;51:883–890. doi: 10.1073/pnas.51.5.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAVIS W. M. Successful treatment of pneumococcal pneumonia with combination of chloramphenicol and penicillin. Am J Med Sci. 1954 Apr;227(4):391–397. doi: 10.1097/00000441-195404000-00004. [DOI] [PubMed] [Google Scholar]
  7. DUBUY H. G., DUBUY H. G., RILEY F., SHOWACRE J. L. TETRACYCLINE FLUORESCENCE IN PERMEABILITY STUDIES OF MEMBRANES AROUND INTRACELLULAR PARASITES. Science. 1964 Jul 10;145(3628):163–165. doi: 10.1126/science.145.3628.163. [DOI] [PubMed] [Google Scholar]
  8. Davies J. Effects of streptomycin and related antibiotics on protein synthesis. Antimicrob Agents Chemother (Bethesda) 1965;5:1001–1005. [PubMed] [Google Scholar]
  9. EAGLE H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952 Oct;13(4):389–399. doi: 10.1016/0002-9343(52)90293-3. [DOI] [PubMed] [Google Scholar]
  10. Farrar W. E., Jr, O'Dell N. M., Krause J. M. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics. Ann Intern Med. 1967 Oct;67(4):733–743. doi: 10.7326/0003-4819-67-4-733. [DOI] [PubMed] [Google Scholar]
  11. GARROD L. P., WATERWORTH P. M. Methods of testing combined antibiotic bactericidal action and the significance of the results. J Clin Pathol. 1962 Jul;15:328–338. doi: 10.1136/jcp.15.4.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GORINI L., KATAJA E. STREPTOMYCIN-INDUCED OVERSUPPRESSION IN E. COLI. Proc Natl Acad Sci U S A. 1964 Jun;51:995–1001. doi: 10.1073/pnas.51.6.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldberg I. H. Mode of action of antibiotics. II. Drugs affecting nucleic acid and protein synthesis. Am J Med. 1965 Nov;39(5):722–752. doi: 10.1016/0002-9343(65)90094-x. [DOI] [PubMed] [Google Scholar]
  14. HAFEZ F. F., STEWART S. M., BURNET M. E. PENICILLIN LEVELS IN SPUTUM. Thorax. 1965 May;20:219–225. doi: 10.1136/thx.20.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. JARDETZKY O., JULIAN G. R. CHLORAMPHENICOL INHIBITION OF POLYURIDYLIC ACID BINDING TO E. COLI RIBOSOMES. Nature. 1964 Jan 25;201:397–398. doi: 10.1038/201397a0. [DOI] [PubMed] [Google Scholar]
  16. JAWETZ E., GUNNISON J. B. Antibiotic synergism and antagonism; an assessment of the problem. Pharmacol Rev. 1953 Jun;5(2):175–192. [PubMed] [Google Scholar]
  17. JAWETZ E., GUNNISON J. B., SPECK R. S., COLEMAN V. R. Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin. AMA Arch Intern Med. 1951 Mar;87(3):349–359. doi: 10.1001/archinte.1951.03810030022002. [DOI] [PubMed] [Google Scholar]
  18. Kalmanson G. M., Hubert E. G., Montgomerie J. Z., Guze L. B. Killing of microbial protoplasts by serum. Antimicrob Agents Chemother (Bethesda) 1966;6:304–307. doi: 10.1128/AAC.6.3.304. [DOI] [PubMed] [Google Scholar]
  19. Kubota M. Y., Montgomerie J. Z., Potter C. S., Kalmanson G. M., Guze L. B. Effect of penicillin concentration on "protoplast" production of Streptococcus faecalis. Antimicrob Agents Chemother (Bethesda) 1966;6:300–303. doi: 10.1128/AAC.6.3.300. [DOI] [PubMed] [Google Scholar]
  20. Kunin C. M. A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med. 1967 Jul;67(1):151–158. doi: 10.7326/0003-4819-67-1-151. [DOI] [PubMed] [Google Scholar]
  21. LEPPER M. H., DOWLING H. F. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin. AMA Arch Intern Med. 1951 Oct;88(4):489–494. doi: 10.1001/archinte.1951.03810100073006. [DOI] [PubMed] [Google Scholar]
  22. Luzzatto L., Apirion D., Schlessinger D. Mechanism of action of streptomycin in E. coli: interruption of the ribosome cycle at the initiation of protein synthesis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):873–880. doi: 10.1073/pnas.60.3.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MACGREGOR A. R., STEWART S. M., TURNBULL F. W. The influence of chemotherapy on the bacterial content of tuberculous pulmonary lesions. Tubercle. 1956 Dec;37(6):388–403. doi: 10.1016/s0041-3879(56)80183-9. [DOI] [PubMed] [Google Scholar]
  24. MANTEN A., WISSE M. J. Antagonism between antibacterial drugs. Nature. 1961 Nov 18;192:671–672. doi: 10.1038/192671a0. [DOI] [PubMed] [Google Scholar]
  25. MCCUNE R., DINEEN P., BATTEN J. C. The influence of antimicrobial agents on total populations of Staphylococci in animal tissues. J Immunol. 1960 Nov;85:447–464. [PubMed] [Google Scholar]
  26. MITCHISON D. A. Microbial genetics and chemotherapy. Br Med Bull. 1962 Jan;18:74–80. doi: 10.1093/oxfordjournals.bmb.a069939. [DOI] [PubMed] [Google Scholar]
  27. Massell B. F., Michael J. G., Michael T., Amezcua J. Temporary suppression of penicillinase-producing staphylococci in the throat flora by oxytetracycline. Am J Med Sci. 1966 Sep;252(3):314–322. doi: 10.1097/00000441-196609000-00011. [DOI] [PubMed] [Google Scholar]
  28. McDERMOTT W. Microbial persistence. Yale J Biol Med. 1958 Feb;30(4):257–291. [PMC free article] [PubMed] [Google Scholar]
  29. McDonald S. Transduction of antibiotic resistance in Staphylococcus aureus. Lancet. 1966 Nov 19;2(7473):1107–1110. doi: 10.1016/s0140-6736(66)92196-9. [DOI] [PubMed] [Google Scholar]
  30. Meynell E., Datta N. Mutant drug resistant factors of high transmissibility. Nature. 1967 May 27;214(5091):885–887. doi: 10.1038/214885a0. [DOI] [PubMed] [Google Scholar]
  31. Montgomerie J. Z., Kalmanson G. M., Hewitt W. L., Guze L. B. Effectiveness of antibiotics against the bacterial and "protoplast" phases of pyelonephritis. Antimicrob Agents Chemother (Bethesda) 1965;5:427–430. [PubMed] [Google Scholar]
  32. NEWTON B. A. Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations. J Gen Microbiol. 1954 Jun;10(3):491–499. doi: 10.1099/00221287-10-3-491. [DOI] [PubMed] [Google Scholar]
  33. Novick R. P., Morse S. I. In vivo transmission of drug resistance factors between strains of Staphylococcus aureus. J Exp Med. 1967 Jan 1;125(1):45–59. doi: 10.1084/jem.125.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. OVERHOLT E. L., TIGERTT W. D., KADULL P. J., WARD M. K., CHARKES N. D., RENE R. M., SALZMAN T. E., STEPHENS M. An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics. Am J Med. 1961 May;30:785–806. doi: 10.1016/0002-9343(61)90214-5. [DOI] [PubMed] [Google Scholar]
  35. PERKINS H. R. Chemical structure and biosynthesis of bacterial cell walls. Bacteriol Rev. 1963 Mar;27:18–55. doi: 10.1128/br.27.1.18-55.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. SABATH L. D., POSTIC B., FINLAND M. Methicillin treatment of severe staphylococcal disease. Observations in 146 cases. N Engl J Med. 1962 Nov 22;267:1049–1057. doi: 10.1056/NEJM196211222672101. [DOI] [PubMed] [Google Scholar]
  37. Salton M. R. Structure and function of bacterial cell membranes. Annu Rev Microbiol. 1967;21:417–442. doi: 10.1146/annurev.mi.21.100167.002221. [DOI] [PubMed] [Google Scholar]
  38. Sanders E., Cluff L. E. Mechanisms of action of antimicrobial agents. Pediatr Clin North Am. 1968 Feb;15(1):3–11. doi: 10.1016/s0031-3955(16)32084-3. [DOI] [PubMed] [Google Scholar]
  39. Strominger J. L., Tipper D. J. Bacterial cell wall synthesis and structure in relation to the mechanism of action of penicillins and other antibacterial agents. Am J Med. 1965 Nov;39(5):708–721. doi: 10.1016/0002-9343(65)90093-8. [DOI] [PubMed] [Google Scholar]
  40. Verwey W. F., Williams H. R., Jr, Kalsow C. Penetration of chemotherapeutic agents into tissues. Antimicrob Agents Chemother (Bethesda) 1965;5:1016–1024. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES